glp-1 agonist definition Agonists Explained: Definition, How They Work, Side Effects GLP-1 | Summary

Semaglutide and Liraglutide: Clinical Trial Highlights Recent clinical trials exploring GLP-1 receptor agonists for NASH treatment have yielded promising results, establishing these agents as potential therapeutic options for this previously difficult-to-treat condition

The FDA approved saxagliptin, linagliptin, and alogliptin, and the European Union and Japan approved vildagliptin, anagliptin, teneligliptin, trelagliptin, and omarigliptin

Proinflammatory cytokine expression in the myocardium has been shown to be reduced by GLP-1R agonists, which directly protects the heart against oxidative stress and inflammation

de Leeuw, C

doi:10.1016/j.bbr.2019.111932 49

The emerging thinking among those working in this field, and reflected in a statement by the Endocrine Society, is that obesity is due to two related but distinct processes: the already mentioned energy imbalance (eating more calories than the body expends) and the resetting of the body weight set point the weight that the body determines as its goal to a higher value